SUBSCRIBE
SUBSCRIBE
News   Policy

IntelliPharmaCeutics Provides Update on Activities Related to Venlafaxine Hydrochloride Extended Release Capsules

July 6, 2010 | 
1 min read
TORONTO, July 2, 2010 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), today announced the following with regard to its generic drug commercialization activities.
Legal
MORE ON THIS TOPIC
Illustration of man walking in the beach between two blue seas, surreal abstract path concept
Rare disease
FDA’s Bespoke Pathway To Focus on Gene Editing and RNA-Based Treatments for Rare Diseases
February 23, 2026
 · 
3 min read
 · 
Nick Paul Taylor
Contemporary art collage. Businessmen, employees walking into open door symbolizing new opportunities. Way to success. Concept of business, promotion, motivation, ambitions and ideas
Government
Kennedy Ally Departs CDC Amid Leadership Shake-Up
February 23, 2026
 · 
1 min read
 · 
Annalee Armstrong
Collage halftone banner with two hands that put objects on scales. Halftone hands holding circle and square and put them on the scales. Concept of business balance in teamwork. Vector illustration.
Legal
REGENXBIO Secures Legal Win in Gene Therapy Patent Battle Vs. Sarepta
February 23, 2026
 · 
2 min read
 · 
Tristan Manalac
protesters group silhouettes with american flag
Opinion
Policymakers Must Sustain American Life Sciences Leadership
February 20, 2026
 · 
4 min read
 · 
Dan Leonard